Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model
ABSTRACT Probiotics have been widely used to prevent primary Clostridioides difficile infection (pCDI); however, there are fewer studies on their therapeutic aspects for pCDI. In this study, high doses of Bifidobacterium breve YH68 were used alone or in combination with vancomycin (VAN) and metronid...
Main Authors: | Jingpeng Yang, Lingtong Meng, Hong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-04-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00672-22 |
Similar Items
-
Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile
by: Jingpeng Yang, et al.
Published: (2019-08-01) -
Transcriptome Analysis of the Clostridioides difficile Response to Different Doses of Bifidobacterium breve
by: Jingpeng Yang, et al.
Published: (2020-07-01) -
Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection — An observational cohort study
by: Sylvia Polivkova, et al.
Published: (2021-02-01) -
Effect of Bifidobacterium breve in Combination With Different Antibiotics on Clostridium difficile
by: Jingpeng Yang, et al.
Published: (2018-12-01) -
Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China
by: Li X, et al.
Published: (2024-01-01)